FSD Pharma Receives Approval for Phase-1 Multiple Ascending Doses Clinical Trial
27 Jun 2024 //
ACCESSWIRE
Lucid Psycheceuticals Files for Patent On Formulations of Palmitoylethanolamide
13 Jul 2022 //
BUSINESSWIRE
LUCID Partners With Japanese Pharmaceutical Company for Alzheimer’s Disease
02 Jun 2022 //
BUSINESSWIRE
FSD Pharma Announces Closing of Lucid Psycheceuticals Acquisition
21 Sep 2021 //
BUSINESSWIRE